Copyright 2025 The Associated Press. All Rights Reserved. Deforestation is visible near the areas of several wood pellet production companies in Pohuwato, Gorontalo ...

The nasal spray Spravato ... which is the brain's most abundant excitatory neurotransmitter and can reduce symptoms in as little as 24 hours. Johnson & Johnson said that because there are risks ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

PORTLAND, Ore. — Utah’s Great Salt Lake, the largest saltwater lake in the Western Hemisphere, hit a troubling milestone in 2022, dropping to its lowest water level since record-keeping began in 1847.

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

In addition to ecological and economic loss, the shrinking lake also poses health risks as a source of toxic dust for the 1.2 million people in the Salt Lake City metro region. "As the lake ...

The World Health Organization 2024 report recently urged world leaders to “reduce pollution-related diseases and cut carbon emissions,” considering that air pollution—particularly extremely ...

All but one of the patients saw their tumors shrink or stop growing after receiving infusions once a week for eight to 12 weeks. Scientists also tested the therapy on five monkeys with liver ...